Results 291 to 300 of about 4,829,888 (359)
Some of the next articles are maybe not open access.

FDA Regulation of Prescription Drugs

New England Journal of Medicine, 2017
Over the past 5 years, the FDA has approved 182 new drugs. This overview explains the FDA’s drug-approval process, including its approach to benefit–risk assessment, drug labeling, risk evaluation and mitigation strategies, and postmarketing surveillance.
Audrey L, Gassman   +2 more
openaire   +4 more sources

2017 FDA drug approvals

Nature Reviews Drug Discovery, 2018
This corrects the article DOI: 10.1038/nrd.2018.4.
openaire   +5 more sources

2014 FDA drug approvals

Nature Reviews Drug Discovery, 2015
The FDA approved 41 new therapeutics in 2014, but the bumper year fell short of the commercial power of the drugs approved in 2013.
openaire   +4 more sources

2019 FDA drug approvals

Nature Reviews Drug Discovery, 2020
The FDA approved 48 new drugs last year, keeping up the momentum of recent years. The FDA approved 48 new drugs last year, keeping up the momentum of recent years.
openaire   +3 more sources

U.S. FDA Approved Drugs from 2015-June 2020: A Perspective.

Journal of Medicinal Chemistry, 2021
In the present work, we report compilation and analysis of 245 drugs, including small and macromolecules approved by the U.S. FDA from 2015 until June 2020. Nearly 29% of the drugs were approved for the treatment of various types of cancers.
Priyadeep Bhutani   +7 more
semanticscholar   +1 more source

A Decade of FDA-Approved Drugs (2010-2019): Trends and Future Directions.

Journal of Medicinal Chemistry, 2021
A total of 378 novel drugs and 27 biosimilars approved by the U.S. Food and Drug Administration (FDA) between 2010 and 2019 were evaluated according to approval numbers by year, therapeutic areas, modalities, route of administration, first-in-class ...
Dean G. Brown, Heike J Wobst
semanticscholar   +1 more source

FDA drug classification system

American Journal of Health-System Pharmacy, 1991
The purpose and use of the FDA's classification system for new drug products are described. Investigational new drug applications (INDs) and new drug applications (NDAs) are submitted to the FDA's Center for Drug Evaluation and Research. To establish the priority of the product in the review process, expert reviewers classify each product according to ...
M D, Sanborn, H N, Godwin, J D, Pessetto
openaire   +2 more sources

Fluorine-containing drugs approved by the FDA in 2019

Chinese Chemical Letters, 2020
Eleven new fluorine-containing FDA-approved drugs have been profiled and details of their discovery and preparation are discussed. Therapeutic areas include schizophrenia, migraine, multiple sclerosis, insomnia, rheumatoid arthritis, anti-tuberculosis ...
Haibo Mei   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy